Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Global Transfer Membrane Market is Predict to reach $418.9 Million by 2028, at a CAGR of 4.7%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Transfer Membrane Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Transfer Membrane Market size is expected to reach $418.9 Million by 2028, rising at a market growth of 4.7% CAGR during the forecast period.

The Nitrocellulose segment is showcasing a CAGR of 4.8% during (2022 - 2028). This is owing to the fact that these membranes are simple to hydrate and provide a low background signal for various applications. Furthermore, these membranes are also excellent for identifying low molecular weight proteins and may be utilized for nucleic acid analysis and dot/slot blotting. Hence, the sector is anticipated to be driven by various applications for nitrocellulose transfer membranes.

The Dry Electro Blotting (Dry Transfer) segment is leading the Global Transfer Membrane Market by Transfer Method in 2021 thereby, achieving a market value of $164.2 Million by 2028. This is due to the provided benefits over other types of transfer membranes. They don't need the transfer of biological molecules utilizing solutions or buffers and are relatively easy to use. As they may be used with several detection methods, they are a well-liked choice for several molecular biology research applications due to their advantages, which include a quick transfer speed and an easy-to-use method of operation.

The Southern Blotting segment has shown the growth rate of 4.9% during (2022 - 2028). This is because the method has several applications in DNA fingerprinting technology. Studies based on restriction fragment length polymorphism, paternity tests, and criminal investigations may all employ this technology. The technique is also used to diagnose several genetic abnormalities, broadening its use in carrier screening testing.

The Biopharmaceutical & Pharmaceutical Companies segment is leading the Global Transfer Membrane Market by End-User in 2021 thereby, achieving a market value of $258.4 Million by 2028. This is owing to their increased research and development efforts for developing innovative medicines and vaccines. In addition, many investments would likely impact the market and increase the use of transfer membranes and other molecular biology techniques. Hence, the high investments in the sector and the increased research & development are expected to further drive the segment's growth.

The North America market dominated the Global Transfer Membrane Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $147 Million by 2028. The Europe market is exhibiting a CAGR of 4% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 5.6% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/transfer-membrane-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p.A.

Global Transfer Membrane Market Segmentation

By Product

  • PVDF
  • Nitrocellulose
  • Nylon

By Transfer Method

  • Dry Electro Blotting (Dry Transfer)
  • Semi-dry Electro Blotting (Semi-dry Transfer)
  • Wet or Tank Transfer
  • Others

By Application

  • Western Blotting
  • Southern Blotting
  • Northern Blotting
  • Others

By End-User

  • Biopharmaceutical & Pharmaceutical Companies
  • Academic & Research Institutes
  • Diagnostic Labs

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Abcam Plc
  • Santa Cruz Biotechnology, Inc.
  • ATTO Corporation
  • Azure Biosystems, Inc.
  • GVS S.p.A

Related Reports:



SUBSCRIPTION MODEL